Opportunity Information: Apply for PA 07 419
Apply for PA 07 419
- The National Institutes of Health in the health income security and social services sector is offering a public funding opportunity titled "Developmental Mechanisms of Human Structural Birth Defects (P01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.865 Child Health and Human Development Extramural Research.
- This funding opportunity was created on Dec 3, 2008 and posted on Dec 3, 2008.
- Applicants must submit their applications by May 25, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Private institutions of higher education For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Regional Organizations U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Developmental Mechanisms of Human Structural Birth Defects (P01) opportunity (Funding Opportunity Number PA 07-419) is a National Institutes of Health (NIH) program announcement designed to fund large, collaborative Program Project (P01) grants focused on understanding why structural congenital malformations happen and how they develop. The central goal is to push forward research that connects developmental biology with genetics and human disease by combining basic laboratory work, translational studies that move discoveries toward practical use, and clinical research grounded in patient observations and samples. The emphasis is on projects that do more than run in parallel; NIH is looking for interactive, multidisciplinary teams where the different parts genuinely inform each other and produce results that would be hard to achieve through separate, stand-alone grants.
A key structural requirement is that each application must include at least three linked component projects, and at least one of those projects must be clinical or translational in nature. In practice, this means applicants need to assemble a program that spans multiple levels of investigation, such as gene discovery and functional validation, mechanistic studies in development, and a human-facing component like patient cohort characterization, clinical phenotyping, human tissue work, or translational approaches that can bridge into diagnostics or intervention strategies. NIH is signaling that strong proposals will treat clinical insight and real-world human biology as an integral part of the overall program rather than an optional add-on.
The program also requires a tight scientific through-line across all components. The projects must share a common central theme, focus, or objective centered on a specific developmental defect or malformation. That shared target must be meaningfully comparable between humans and an animal model, in the sense that the defect is analogous or homologous across species either genetically, mechanistically, biologically, or phenotypically. In other words, the animal work is expected to be directly relevant to the human condition being studied, not simply general developmental research. Any animal model can be used, mammalian or non-mammalian, as long as it clearly advances the same overarching question and aligns with the human malformation theme. This flexibility allows applicants to choose the model system that best captures the biology of the defect, whether that is mouse, zebrafish, chick, Xenopus, Drosophila, or other systems, provided the cross-species relevance is well-justified.
Because P01s can vary widely in ambition and scope, NIH does not set a single standard award size or duration for this announcement. Instead, the agency expects the budget and project length to match the scientific plan, and it notes that both the number of awards and the total dollars ultimately depend on the quality of applications received as well as their proposed costs and timelines. The core message is that strong, well-integrated, high-impact programs can be supported at the scale needed to accomplish their aims, but awards will be made competitively based on merit.
From an administrative standpoint, this is a discretionary grant opportunity in the Health category (CFDA 93.865, Child Health and Human Development Extramural Research), posted December 3, 2008, with an original and current closing date of May 25, 2010, and an archive date of June 25, 2010. Cost sharing or matching is not required, which is typical for many NIH research grants. While the announcement is archived, the summary still captures the NIH expectations for the kind of P01 program project they were soliciting: integrated teams, multiple interdependent projects, and a clear translational or clinical anchor tied to a specific structural birth defect.
Eligibility is broad and includes public and state-controlled institutions of higher education, private institutions of higher education, for-profit organizations other than small businesses, nonprofit organizations (including both 501(c)(3) and certain non-501(c)(3) entities), and state governments. The eligibility language also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), regional organizations, eligible federal agencies, and U.S. territories or possessions. This wide eligibility reflects NIH’s intent to attract strong interdisciplinary teams wherever they are based, including institutions with missions focused on serving underrepresented communities.
Overall, the opportunity is best understood as NIH’s push to fund coordinated, multi-project research programs that can connect genetic and developmental mechanisms to real human structural birth defects, using animal models as powerful tools to test causality and mechanisms, and pairing those findings with clinical or translational work that keeps the science anchored to human malformations and their underlying biology.
Frequently Asked Questions (FAQs)
What is the "Developmental Mechanisms of Human Structural Birth Defects (P01)" opportunity?
This opportunity is an NIH program announcement to support large, collaborative Program Project (P01) grants focused on understanding why structural congenital malformations happen and how they develop. The emphasis is on integrated programs that connect developmental biology, genetics, and human disease through basic, translational, and clinical research.
What is the Funding Opportunity Number for this announcement?
The Funding Opportunity Number is PA 07-419.
What type of grant mechanism is being solicited?
The announcement solicits Program Project (P01) grants. These are designed for multi-project, team-based programs where the component projects are linked by a central theme and are expected to meaningfully interact.
What is NIH looking for in terms of collaboration and integration?
NIH is looking for interactive, multidisciplinary teams where the component projects do more than operate in parallel. The different parts of the program should inform each other and produce outcomes that would be difficult to achieve through separate stand-alone grants.
How many component projects are required in an application?
Each application must include at least three linked component projects.
Is a clinical or translational component required?
Yes. At least one of the component projects must be clinical or translational in nature.
What counts as a clinical or translational project under this program?
Based on the description provided, examples include work involving patient cohort characterization, clinical phenotyping, studies using human tissues, and translational approaches that bridge discoveries toward diagnostics or intervention strategies. The intent is that the human-facing component is integral to the overall program.
Does the program need to focus on a specific birth defect or can it be broad?
The projects must share a common central theme, focus, or objective centered on a specific developmental defect or malformation. The program is not described as supporting general developmental research without a direct link to a specific structural birth defect theme.
How should the animal model relate to the human malformation being studied?
The shared target (the defect or malformation) must be meaningfully comparable between humans and an animal model. The defect should be analogous or homologous across species in a way that is justified genetically, mechanistically, biologically, or phenotypically. The animal work is expected to be directly relevant to the human condition being studied.
Are only mammalian animal models allowed?
No. Any animal model can be used, mammalian or non-mammalian, as long as it clearly advances the same overarching question and aligns with the human malformation theme. Examples mentioned include mouse, zebrafish, chick, Xenopus, and Drosophila.
What kinds of research approaches does NIH expect across the program?
The announcement emphasizes combining basic laboratory work, translational studies that move discoveries toward practical use, and clinical research grounded in patient observations and samples. In practice, this can span multiple levels of investigation, such as gene discovery and functional validation, mechanistic studies in development, and a human-facing clinical or translational component.
Is there a standard award size or project duration for this announcement?
No. NIH does not set a single standard award size or duration for this program announcement. The budget and project length are expected to match the scientific plan.
How are the number of awards and total funding determined?
The number of awards and total dollars depend on the quality of applications received as well as proposed costs and timelines. Awards are made competitively based on merit.
Is cost sharing or matching required?
No. Cost sharing or matching is not required.
What is the CFDA number and program area listed?
The CFDA number is 93.865, listed under Child Health and Human Development Extramural Research.
What category is this opportunity listed under?
It is listed as a discretionary grant opportunity in the Health category.
When was the opportunity posted, and what are the closing and archive dates?
The opportunity was posted on December 3, 2008. The original and current closing date is May 25, 2010. The archive date is June 25, 2010.
Is this announcement archived, and what does that imply based on the description provided?
Yes, it is archived. The description indicates that while the announcement is archived, the summary still captures NIH expectations for the type of P01 program project they were soliciting (integrated teams, multiple interdependent projects, and a clear translational or clinical anchor tied to a specific structural birth defect).
Who is eligible to apply?
Eligibility is broad and includes public and state-controlled institutions of higher education, private institutions of higher education, for-profit organizations other than small businesses, nonprofit organizations (including both 501(c)(3) and certain non-501(c)(3) entities), and state governments.
Are there specific institution types explicitly highlighted as eligible?
Yes. The eligibility language highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), regional organizations, eligible federal agencies, and U.S. territories or possessions.
What is the main scientific goal of the program?
The central goal is to advance research that explains why structural congenital malformations occur and how they develop, by connecting developmental biology with genetics and human disease through coordinated basic, translational, and clinical studies.
What is NIH signaling about the role of clinical insight in these applications?
NIH is signaling that clinical insight and real-world human biology should be an integral part of the overall program rather than an optional add-on, consistent with the requirement that at least one project be clinical or translational.
Can the component projects be independent as long as they fall under the same general area?
The description emphasizes that NIH wants more than parallel projects. The program should be tightly integrated with a clear scientific through-line across components, where the projects genuinely inform each other and are interdependent.
Browse more opportunities from the same category: Health Income Security and Social Services
Next opportunity: Americas Fellowship in Reproductive Sciences (F05)
Previous opportunity: Division of Global Public Health Capacity Development Pakistan FELTP Infectious Disease Surveillance, Investigation, and Technical Assistance
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 07 419
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 07 419) also looked into and applied for these:
| Funding Opportunity |
|---|
| Americas Fellowship in Reproductive Sciences (F05) Apply for PA 07 453 Funding Number: PA 07 453 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Adverse Outcomes of Assisted Reproductive Technologies (P01) Apply for PA 08 103 Funding Number: PA 08 103 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Resource Program Grants in Bioformatics (P41) Apply for PA 08 180 Funding Number: PA 08 180 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| NICHDs Institutional Predoctoral and Postdoctoral Training Program in Reproductive, Obstetric, Perinatal and Pediatric Epidemiology and Pharmacoepidemiology (T32) Apply for PAR 08 271 Funding Number: PAR 08 271 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Data Coordinating Center for the Collaborative Pediatric Critical Care Research Network (U01) Apply for RFA HD 08 027 Funding Number: RFA HD 08 027 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Predoctoral Training Program in Systems Biology of Developmental Biology Birth Defects (T32) Apply for PAR 08 054 Funding Number: PAR 08 054 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Preterm Birth in Nulliparous Women An Understudied Population at Great Risk (U10) Apply for RFA HD 08 029 Funding Number: RFA HD 08 029 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $130,000 |
| Biology of Manual Therapies (R21) Apply for PAR 06 312 Funding Number: PAR 06 312 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Innovative Therapies and Clinical Studies for Screenable Disorders (R21) Apply for PAR 06 342 Funding Number: PAR 06 342 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Innovative Therapies and Clinical Studies for Screenable Disorders (R03) Apply for PAR 06 341 Funding Number: PAR 06 341 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $50,000 |
| Shared Neurobiology of Fragile X Syndrome and Autism (R03) Apply for PA 06 429 Funding Number: PA 06 429 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $50,000 |
| Shared Neurobiology of Fragile X Syndrome and Autism (R21) Apply for PA 06 430 Funding Number: PA 06 430 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Educational Programs for Population Research (R25) Apply for PA 06 507 Funding Number: PA 06 507 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Transmission of Human Immunodeficiency Virus (HIV) In Semen (R01) Apply for PA 07 044 Funding Number: PA 07 044 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Collaborative Research for Molecular and Genomic Studies of Basic Behavior in Animal Models (R01) Apply for PA 07 096 Funding Number: PA 07 096 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Innovative Therapies and Clinical Studies for Screenable Disorders (R01) Apply for PAR 07 184 Funding Number: PAR 07 184 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Vulvodynia Systematic Epidemiologic, Etiologic Or Therapeutic Studies (R01) Apply for PA 07 182 Funding Number: PA 07 182 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Translational Research in Eating Disorders (R01) Apply for PA 07 285 Funding Number: PA 07 285 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Fragile X Pre mutation and Ovarian Function (R01) Apply for PA 07 219 Funding Number: PA 07 219 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Fragile X Pre mutation and Ovarian Function (R03) Apply for PA 07 220 Funding Number: PA 07 220 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 419", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
